Global Newborn Screening Market 2018-2027: Driven by Rising Incidences of Critical Congenital Heart Defects and Government Support Towards Newborn Child Health - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Newborn Screening Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Newborn Screening Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include rising incidences of critical congenital heart defects (CCHD) and government support towards newborn child health.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Report Highlights

• The report provides a detailed analysis on current and future market trends to identify the investment opportunities
• Market forecasts till 2027, using estimated market values as the base numbers
• Key market trends across the business segments, Regions and Countries
• Key developments and strategies observed in the market
• Market Dynamics such as Drivers, Restraints, Opportunities and other trends
• In-depth company profiles of key players and upcoming prominent players
• Growth prospects among the emerging nations through 2027
• Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 Technology Analysis

1.5 Product Analysis

1.6 End User Analysis

1.7 Strategic Benchmarking

1.8 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Rising Incidences of Critical Congenital Heart Defects (CCHD)

3.1.2 Government Support Towards Newborn Child Health

3.1.3 Recent Technological Developments in Newborn Screening

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Newborn Screening Market, By Test Type

4.1 Dry Blood Spot Test

4.2 Hearing Screen Test

4.3 Critical Congenital Heart Diseases (CCHD) Test

4.4 Urine Test

4.5 Other Test Types

5 Newborn Screening Market, By Technology

5.1 DNA-Based Assays

5.2 Electrophoresis

5.3 Hearing Screen Technology

5.4 Immunoassays and Enzymatic Assays

5.5 Pulse Oximetry Screening Technology

5.6 Tandem Mass Spectrometry (TMS)

6 Newborn Screening Market, By Product

6.1 Device

6.1.1 Hearing Screening Devices

6.1.2 Laparoscope

6.1.3 Mass Spectrometer

6.1.4 Pulse Oximeter

6.1.5 Retinoscope

6.1.6 Ultrasound Machine

6.2 Reagents Assay Kits

7 Newborn Screening Market, By End User

7.1 Diagnostic Centers

7.2 Hospitals

7.3 Maternity & Specialty Clinics

7.4 Ambulatory Care

7.5 Clinics

7.6 Government agencies

7.7 Nursing Homes

7.8 Local health departments

7.9 International organizations or Community organizations

8 Newborn Screening Market, By Disease Type

8.1 Biotinidase Deficiency

8.2 Blood Spot Disease

8.3 Congenital Adrenal Hyperplasia (CAH)

8.4 Congenital Hypothyroidism

8.5 Critical Congenital Cardiac Disease

8.6 Cystic Fibrosis (CF)

8.7 Hearing Disability

8.8 Maple Syrup Urine Disease (MSUD)

8.9 MCAD deficiency

8.10 Phenylketonuria (PKU)

8.11 Severe Combined immunodeficiency (SCID)

8.12 Sickle Cells Disease

8.13 Thyroid Disorder

8.14 ToxoplasmosisGalactosemia

8.15 Tyrosinemia

9 Newborn Screening Market, By Geography

9.1 North America

9.2 Europe

9.3 Asia Pacific

9.4 Middle East

9.5 Latin America

9.6 Rest of the World (RoW)

10 Key Player Activities

10.1 Mergers & Acquisitions

10.2 Partnerships, Joint Ventures, Collaborations and Agreements

10.3 Product Launch & Expansions

10.4 Other Activities

11 Leading Companies

11.1 AB Sciex

11.2 Agilent Technologies Inc.

11.3 Bio-Rad Laboratories Inc.

11.4 Covidien PLC

11.5 GE Healthcare

11.6 Masimo Corporation

11.7 Medtronic Inc.

11.8 Natus Medical Incorporated

11.9 PerkinElmer Inc.

11.10 Trivitron Healthcare

11.11 Waters Corporation

11.12 ZenTech S.A.

For more information about this report visit https://www.researchandmarkets.com/research/kcpw8g/global_newborn?w=4